AVITA Medical Clinches Top Honors: Best Product Award at the American Association for the Surgery of Trauma

In the world of regenerative medicine, AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) is making waves. Their groundbreaking RECELL® System has just clinched the “Best Product” award at the Annual Meeting of the American Association for the Surgery of Trauma (AAST), for the second consecutive year.

Imagine this: in its 82nd year, the AAST annual meeting brings together over 700 brilliant minds—physicians and scientists alike—focused on unraveling the mysteries of trauma and advancing the field of surgical critical care.

Dr. Carmen Flores, Assistant Professor of Surgery at the Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, took center stage at the conference. Her presentation, titled “RECELL® Spray-On™ Skin Cells: A New Option for Treating Full-Thickness Defects,” drew a captivated audience that filled the room to capacity.

But that’s not all. AVITA Medical’s pivotal trial results for full-thickness skin defects, presented by Dr. Sharon Henry, Professor of Surgery and Director of the Division of Wound Healing and Metabolism at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center, are set to make waves in the medical world. These groundbreaking results were recently accepted for publication in AAST’s esteemed Journal of Trauma and Acute Care Surgery.

AVITA Medical’s RECELL® System isn’t just winning awards; it’s revolutionizing the way we think about skin restoration and regenerative therapies.

In a remarkable show of commitment to diversity, equity, and inclusion, Dr. Sharon Henry spearheaded a workshop for local high school students in collaboration with the AAST Diversity, Equity, and Inclusion Committee. But this was no ordinary workshop; it was a window into the world of trauma surgery as a potential career path.

Imagine high school students, eager and curious, stepping into the shoes of future surgeons. AVITA Medical, along with three other forward-thinking companies, played a pivotal role in supporting this eye-opening workshop.

They provided not only their personnel but also essential supplies, including the groundbreaking RECELL® technology. It’s more than just supporting; it’s about shaping the future of medicine and inspiring the next generation of healthcare heroes.

About AVITA Medical, Inc.

AVITA Medical® is at the forefront of regenerative medicine, pioneering innovative devices and autologous cellular therapies to restore skin. Imagine harnessing the power of your own skin to heal and rejuvenate. That’s what the RECELL® System does. It’s not just cutting-edge; it’s FDA-approved for treating thermal burn wounds, full-thickness skin defects, and repigmenting vitiligo lesions.

But here’s the game-changer: RECELL® creates Spray-On Skin™ cells right at the point of care. This means better outcomes for patients and a new era in medical treatment. AVITA Medical isn’t stopping there; they’re on a mission to develop groundbreaking cellular therapies for various conditions.

Their impact isn’t limited to the U.S.; they’re making waves worldwide. From burns to soft tissue repair, vitiligo to aesthetics, the RECELL® System is transforming lives. It’s TGA-registered in Australia, has the CE-mark in Europe, and holds PMDA approval in Japan. AVITA Medical is more than a company; it’s a force of progress in regenerative medicine.

Leave a Comment